Table 1 Patient’s baseline characteristics, ocular findings and treatments.

From: Microaneurysms cause refractory macular edema in branch retinal vein occlusion

Age (years ± SD)

73 ± 8.4

Gender (male/female)

32/34

Diabetes mellitus (yes/no/unknown)

3/60/3

Hypertension (yes/no/unknown)

31/30/5

Subtype (major BRVO/macular BRVO)

36/30

Initial VA (logMAR) (mean ± SD)

0.32 ± 0.31

Initial CRT (μm) (mean ± SD)

440 ± 140

NPA larger than 5 disc diameters (yes/no/unknown)

23/42/1

NPA larger than 3 disc areas within arcade vessels (yes/no/unknown)

23/42/1

Superficial capillary telangiectasia (yes/no/unknown)

30/10/26

Deep capillary telangiectasia (yes/no/unknown)

40/0/26

Microaneurysms (yes/no)

46/20

Collateral vessels formation (yes/no)

56/10

Initial treatment within 3 months (yes/no)

47/19

Refractory macular edema

34/32

Treatment

 

 STTA

20

 Anti-VEGF therapy

22

 Switch from STTA to anti-VEGF therapy

16

 Vitrectomy

4

 No treatment

4

Retinal scatter laser photocoagulation (yes/no)

35/31

Direct laser photocoagulation (yes/no)

11/55

  1. SD, standard deviation. BRVO, branch retinal vein occlusion, logMAR, logarithm of minimal angle of resolution. CRT, central retinal thickness. NPA, non-perfusion area. STTA, sub-tenon’s capsule injection of triamcinolone acetonide. VEGF, vascular endothelial growth factor.